BAM
Byrne Asset Management’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-86
| Closed | -$2K | – | 549 |
|
|
2023
Q3 | $2K | Hold |
86
| – | – | ﹤0.01% | 471 |
|
|
2023
Q2 | $3K | Hold |
86
| – | – | ﹤0.01% | 502 |
|
|
2023
Q1 | $3K | Hold |
86
| – | – | ﹤0.01% | 495 |
|
|
2022
Q4 | $3.83K | Hold |
86
| – | – | ﹤0.01% | 456 |
|
|
2022
Q3 | $2K | Hold |
86
| – | – | ﹤0.01% | 464 |
|
|
2022
Q2 | $2K | Hold |
86
| – | – | ﹤0.01% | 484 |
|
|
2022
Q1 | $3K | Hold |
86
| – | – | ﹤0.01% | 480 |
|
|
2021
Q4 | $3K | Buy |
+86
| New | +$3K | ﹤0.01% | 483 |
|